ALLEGAN -- Perrigo Co. (Nasdaq: PRGO) announced that it has received final approval from the United States Food and Drug Administration for its abbreviated new drug application for calcium acetate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback